Variation in Endpoints for FDA Approved Migraine Therapies
Sep 07, 2023•2 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Leigh Sharpless discusses her paper, "Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications".
Show References: https://n.neurology.org/content/101/10/e989
For the best experience, listen in Metacast app for iOS or Android